IP Library Granted Patent US 11,413,088
Granted Patent B2
US 11,413,088 · App. 16/152,163 · Granted Aug 16, 2022

Methods and systems for endometrial ablation utilizing radio frequency

Inventors: Akos Toth (Cupertino, CA); Ronald Hundertmark (San Mateo, CA)
Assignee: Minerva Surgical, Inc.
A61B18/1485A61B5/1076A61B18/042A61B2018/0022A61B2018/00214A61B2018/00559A61B2018/00577A61B2018/00666A61B2018/147A61B2090/064A61B2218/008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,413,088
App. No.
16/152,163
Granted
Aug 16, 2022
Kind
B2
Abstract

Methods, systems and devices for endometrial ablation. In accordance with a method, a working end of an RF ablation device is positioned in a patient uterus to contact endometrial tissue, the working end comprising a dielectric wall capable of non-expanded and expanded shapes. An indicator mechanism is operatively coupled to the wall and configured to indicate non-expanded and expanded shapes of the wall.

Claims (14)

1. An electrosurgical system for treating uterine tissue, comprising: a handle comprising an indicator mechanism, the handle having an axially aligned slot formed in a wall thereof and a fixed indicator element positioned alongside a length of the slot; a uterine treatment member; an expandable frame configured to deploy the uterine treatment member between non-expanded and expanded shapes; a translatable sleeve coupled between the handle and the expandable frame for actuating the expandable frame to move the treatment member between the non-expanded and expanded shapes; wherein the indicator mechanism comprises a sliding element fixedly coupled to a proximal end of the translatable sleeve to axially translate in the slot in the handle as the treatment member moves between the non-expanded and expanded shapes; wherein the sliding element has a first zone with a first color and a second zone with a second color different than the first color; and wherein the sliding element is visible though the slot and the fixed indicator element aligns with the first zone with the first color when the treatment element is in the non-expanded shape and aligns with the second zone with the second color when the treatment element is in the expanded shape to visually indicate an extent of opening of the treatment member between the non-expanded and expanded shapes.

2. The system of claim 1 , wherein the treatment member is configured to couple to an energy delivery controller for delivering ablative energy to uterine tissue, and wherein the indicator mechanism generates an electrical signal which is delivered to the energy delivery controller to prevent the energy delivery controller from delivering RF current to the uterine tissue if the treatment member is not opened to a threshold expansion.

3. The system of claim 1 , wherein the first color is red and the second color is green.

4. The system of claim 1 , wherein the treatment member comprises a thin conformable wall at least partially surrounding an interior chamber and having a shape for positioning in a uterine cavity, the wall capable of the non-expanded and expanded shapes.

5. The system of claim 4 , wherein the interior chamber is fluid-tight.

6. The system of claim 5 , wherein the wall is at least partly a dielectric.

7. The system of claim 6 , wherein the wall delivers RF current for ablating tissue.

8. The system of claim 4 , wherein the frame comprises at least one spring element in the interior chamber biasing the thin conformable wall toward the expanded shape.

9. The system of claim 8 , wherein the indicator mechanism is coupled to the frame and indicates expansion of the wall by movement of the frame.

10. The system of claim 8 , wherein the indicator mechanism indicates an axial relationship between first and second axially-extending frame elements.

11. The system of claim 1 , wherein the non-expanded shape is configured for being constrained in a bore of an introducer sleeve.

12. The system of claim 1 , wherein the expanded shape has a triangular configuration for contacting endometrial tissue about a uterine cavity.

13. The system of claim 1 , wherein the uterine treatment member has a plurality of partially expanded shapes for contacting endometrial tissue in varied shapes of uterine cavities.

14. The system of claim 1 , wherein the uterine treatment member has a plurality of partially expanded shapes for contacting endometrial tissue in uterine cavities having varied dimensions.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Feb 5, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: MINERVA SURGICAL, INC.
Reel/Frame 074721/0585 →
SECURITY INTEREST Recorded Jan 30, 2026
From: AXORA MEDICAL, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 074537/0617 →
SECURITY INTEREST Recorded Oct 8, 2021
From: MINERVA SURGICAL, INC.
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 057758/0137 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2019
From: TOTH, AKOS; HUNDERTMARK, RONALD
To: MINERVA SURGICAL, INC.
Reel/Frame 051325/0715 →
Cited By (1)
US 12,369,972